The largest database of trusted experimental protocols

4 protocols using anakinra

1

Investigating Anakinra's Role in LPS-Induced Hearing Loss

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the roles for anakinra in LPS-induced EH, mice were intraperitoneal injected (i.p.) with anakinra (10 mg/kg, Med Chem Express, Monmouth Junction, NJ, USA) or equivalent NS 30 min before LPS challenge. In all cases, hearing and vestibular function were tested on day 5 after first dose of LPS injection. After then, those mice were anesthetized by intraperitoneal injection with a mixture of xylazine (10 mg/kg) and ketamine (100 mg/kg) and inner ears were subjected to protein or RNA expression and EH analysis.
+ Open protocol
+ Expand
2

Inhibition of SARS-CoV-2 Cellular Entry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were pre-incubated with anakinra (an IL-1R inhibitor; MedChemExpress, South Brunswick, NJ, USA), TLR3/dsRNA complex inhibitor (Merck Millipore, Germany), TAK-242 (a TLR4 inhibitor; Merck Millipore, Germany), and infliximab (an anti-TNF-α monoclonal antibody; MedChemExpress) for 30 min. The cells were then treated with SARS-CoV-2 solutions at various dilution ratios and cultured for 48 or 72 h in the presence of each inhibitor. The cytotoxicity of the inhibitors was assessed using the Cell Counting Kit8 in a concentration-dependent manner, and the optimal dosage was determined.
+ Open protocol
+ Expand
3

Targeted miRNA Modulation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCC950 and anakinra were purchased from MedChemExpress (Princeton, NJ, USA) and administered intraperitoneally at 40 mg/kg/day to mice. miR-223 was administered as the synthesized mmu-miR-223 via a nanoparticle. MaxSuppressor In Vivo RNA-LANCEr II (NLE) (Bioscientific, Austin, TX, USA) was used according to the manufacturer’s instructions to administer 100 μg/kg/day mmu-miR-22 mimics intravenously.
+ Open protocol
+ Expand
4

Comprehensive Reagent Acquisition for Biological Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
PMA (catalog 10008014) was purchased from Cayman Chemical. NAC (catalog A7250) and cis-diammineplatinum(II) dichloride (catalog 479306) were purchased from MilliporeSigma. MTT (catalog M6494), DCF (catalog C6827), and MitoSOX (catalog M36008) were purchased from Invitrogen. The ICAM1 inhibitor, A205804 (catalog sc-203484), was purchased from Santa Cruz Biotechnology. The IL-1R antagonist, anakinra (catalog HY-108841), was purchased from MedChemExpress. GM-CSF and M-CSF were purchased from PeproTech. GRO-α, IL-1α, IL-1β, IL-18, MIP-1β, SDS-1α, and VEGF were purchased from CROYEZ. Neutralizing antibodies against human IL-1β (4H5) and isotype-matched IgG (T8E5) were purchased from InvivoGen. ELISA kits for human IL-1β (catalog ARG80101) and mouse IL-1β (catalog ARG80196) were purchased from Arigo Biolaboratories. Clinical medications used in the present study and corresponding suppliers were DTX (Enzo), axitinib (Pfizer), PIO (Takeda), atezolizumab (Roche), cabozantinib (Ipsen), and Asadin (TTY Biopharm).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!